Third Harmonic Bio Inc (THRD)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
CEO:
Natalie C. Holles
Employees:
20
300 TECHNOLOGY SQUARE, 8TH FLOOR, CAMBRIDGE, MA, 02139
415-215-6023

We are a clinical-stage biopharmaceutical company focused on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. Our principal executive offices are located at 300 Technology Square, 8th Floor, Cambridge, Massachusetts.

Are you looking for this stock instead?

View recent insider trading info

Third Harmonic Bio Inc YCharts
Yahoo! Finance finviz

Funds Holding THRD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding THRD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PEREZ ROBERT J

  • Director
 0 2023-03-06 2

IWICKI MARK T

  • Director
 0 2023-03-06 2

SOLOWAY THOMAS P

  • Director
 0 2023-03-06 2

BONITA DAVID P

  • Director
  • 10% Owner
 0 2023-03-06 3

HOLLES NATALIE C. CEO

  • Officer
  • Director
 0 2023-03-06 2

CONNER EDWARD R. CHIEF MEDICAL OFFICER

  • Officer
 0 2023-03-06 2

HO ROBERT CHIEF FINANCIAL OFFICER

  • Officer
 0 2023-03-06 2

GLADSTONE MICHAEL

  • Director
 0 2023-03-06 2

SEIDEL HANS MARTIN

  • Director
 0 2023-03-06 2

RAY ADRIAN S. CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2023-03-06 3

PERSON JULIE CHIEF ADMINISTRATIVE OFFICER

  • Officer
 0 2023-03-06 2

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
4,338,167 2022-12-20 2

LIN SHAO-LEE

  • Director
 13,667 2022-10-26 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VII LLC

  • Director
  • 10% Owner
 5,779,071 2022-09-19 1

ATLAS VENTURE FUND XI, L.P.

ATLAS VENTURE ASSOCIATES XI, L.P.

ATLAS VENTURE ASSOCIATES XI, LLC

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

  • 10% Owner
 10,907,859 2022-09-19 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SOLOWAY THOMAS P - Director

2023-03-08 17:06:43 -0500 2023-03-06 A 76,582 a 76,582 direct

SEIDEL HANS MARTIN - Director

2023-03-08 17:03:12 -0500 2023-03-06 A 6,640 a 6,640 direct

SEIDEL HANS MARTIN - Director

2023-03-08 17:03:12 -0500 2023-03-06 D 6,640 d 0 direct

SEIDEL HANS MARTIN - Director

2023-03-08 17:03:12 -0500 2023-03-06 A 13,667 a 13,667 direct

SEIDEL HANS MARTIN - Director

2023-03-08 17:03:12 -0500 2023-03-06 D 13,667 d 0 direct

IWICKI MARK T - Director

2023-03-08 17:02:25 -0500 2023-03-06 A 13,667 a 13,667 direct

IWICKI MARK T - Director

2023-03-08 17:02:25 -0500 2023-03-06 D 13,667 d 0 direct

IWICKI MARK T - Director

2023-03-08 17:02:25 -0500 2023-03-06 A 35,413 a 35,413 direct

IWICKI MARK T - Director

2023-03-08 17:02:25 -0500 2023-03-06 D 35,413 d 0 direct

SOLOWAY THOMAS P - Director

2023-03-08 17:06:43 -0500 2023-03-06 A 13,667 a 13,667 direct

SOLOWAY THOMAS P - Director

2023-03-08 17:06:43 -0500 2023-03-06 D 13,667 d 0 direct

GLADSTONE MICHAEL - Director

2023-03-08 17:04:30 -0500 2023-03-06 D 13,667 d 0 direct

SOLOWAY THOMAS P - Director

2023-03-08 17:06:43 -0500 2023-03-06 D 76,582 d 0 direct

PEREZ ROBERT J - Director

2023-03-08 17:06:06 -0500 2023-03-06 A 13,667 a 13,667 direct

PEREZ ROBERT J - Director

2023-03-08 17:06:06 -0500 2023-03-06 D 13,667 d 0 direct

HOLLES NATALIE C. - Director - Officer CEO

2023-03-08 17:05:20 -0500 2023-03-06 A 205,000 a 205,000 direct

HOLLES NATALIE C. - Director - Officer CEO

2023-03-08 17:05:20 -0500 2023-03-06 D 205,000 d 0 direct

HOLLES NATALIE C. - Director - Officer CEO

2023-03-08 17:05:20 -0500 2023-03-06 A 360,000 a 360,000 direct

HOLLES NATALIE C. - Director - Officer CEO

2023-03-08 17:05:20 -0500 2023-03-06 A 467,634 a 467,634 direct

HOLLES NATALIE C. - Director - Officer CEO

2023-03-08 17:05:20 -0500 2023-03-06 D 467,634 d 0 direct

BONITA DAVID P - Director - > 10% Owner

2023-03-08 16:59:46 -0500 2023-03-06 A 13,667 a 13,667 direct

BONITA DAVID P - Director - > 10% Owner

2023-03-08 16:59:46 -0500 2023-03-06 D 13,667 d 0 direct

PERSON JULIE - Officer CHIEF ADMINISTRATIVE OFFICER

2023-03-08 17:01:37 -0500 2023-03-06 D 80,000 d 0 direct

HO ROBERT - Officer CHIEF FINANCIAL OFFICER

2023-03-08 16:58:48 -0500 2023-03-06 D 95,000 d 0 direct

HO ROBERT - Officer CHIEF FINANCIAL OFFICER

2023-03-08 16:58:48 -0500 2023-03-06 A 136,000 a 136,000 direct

HO ROBERT - Officer CHIEF FINANCIAL OFFICER

2023-03-08 16:58:48 -0500 2023-03-06 A 367,955 a 367,955 direct

HO ROBERT - Officer CHIEF FINANCIAL OFFICER

2023-03-08 16:58:48 -0500 2023-03-06 D 367,955 d 0 direct

RAY ADRIAN S. - Officer CHIEF SCIENTIFIC OFFICER

2023-03-08 16:58:02 -0500 2023-03-06 A 95,000 a 95,000 direct

RAY ADRIAN S. - Officer CHIEF SCIENTIFIC OFFICER

2023-03-08 16:58:02 -0500 2023-03-06 D 95,000 d 0 direct

RAY ADRIAN S. - Officer CHIEF SCIENTIFIC OFFICER

2023-03-08 16:58:02 -0500 2023-03-06 A 132,000 a 132,000 direct

RAY ADRIAN S. - Officer CHIEF SCIENTIFIC OFFICER

2023-03-08 16:58:02 -0500 2023-03-06 A 309,871 a 309,871 direct

RAY ADRIAN S. - Officer CHIEF SCIENTIFIC OFFICER

2023-03-08 16:58:02 -0500 2023-03-06 D 309,871 d 0 direct

PERSON JULIE - Officer CHIEF ADMINISTRATIVE OFFICER

2023-03-08 17:01:37 -0500 2023-03-06 A 80,000 a 80,000 direct

HO ROBERT - Officer CHIEF FINANCIAL OFFICER

2023-03-08 16:58:48 -0500 2023-03-06 A 95,000 a 95,000 direct

PERSON JULIE - Officer CHIEF ADMINISTRATIVE OFFICER

2023-03-08 17:01:37 -0500 2023-03-06 A 119,000 a 119,000 direct

PERSON JULIE - Officer CHIEF ADMINISTRATIVE OFFICER

2023-03-08 17:01:37 -0500 2023-03-06 A 177,069 a 177,069 direct

PERSON JULIE - Officer CHIEF ADMINISTRATIVE OFFICER

2023-03-08 17:01:37 -0500 2023-03-06 D 177,069 d 0 direct

CONNER EDWARD R. - Officer CHIEF MEDICAL OFFICER

2023-03-08 17:00:42 -0500 2023-03-06 A 95,000 a 95,000 direct

CONNER EDWARD R. - Officer CHIEF MEDICAL OFFICER

2023-03-08 17:00:42 -0500 2023-03-06 D 95,000 d 0 direct

CONNER EDWARD R. - Officer CHIEF MEDICAL OFFICER

2023-03-08 17:00:42 -0500 2023-03-06 A 137,000 a 137,000 direct

CONNER EDWARD R. - Officer CHIEF MEDICAL OFFICER

2023-03-08 17:00:42 -0500 2023-03-06 A 383,288 a 383,288 direct

CONNER EDWARD R. - Officer CHIEF MEDICAL OFFICER

2023-03-08 17:00:42 -0500 2023-03-06 D 383,288 d 0 direct

GLADSTONE MICHAEL - Director

2023-03-08 17:04:30 -0500 2023-03-06 A 13,667 a 13,667 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
THIRD HARMONIC BIO INC THRD 2023-03-29 22:15:04 UTC -12.5967 17.4167 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 21:45:05 UTC -12.5967 17.4167 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 21:15:04 UTC -12.5967 17.4167 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 20:45:06 UTC -12.5967 17.4167 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 20:15:05 UTC -12.5967 17.4167 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 19:45:05 UTC -12.5967 17.4167 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 19:15:05 UTC -12.5967 17.4167 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 18:45:06 UTC -12.6041 17.4241 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 18:15:06 UTC -12.6041 17.4241 600000
THIRD HARMONIC BIO INC THRD 2023-03-29 17:45:06 UTC -12.6041 17.4241 600000
THIRD HARMONIC BIO INC THRD 2023-03-29 17:15:05 UTC -12.6041 17.4241 600000
THIRD HARMONIC BIO INC THRD 2023-03-29 16:45:05 UTC -12.6041 17.4241 600000
THIRD HARMONIC BIO INC THRD 2023-03-29 16:15:05 UTC -12.6041 17.4241 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 15:45:05 UTC -12.6041 17.4241 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 15:15:06 UTC -12.6041 17.4241 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 14:45:06 UTC -12.6041 17.4241 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 14:15:06 UTC -12.6041 17.4241 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 13:45:05 UTC -12.6462 17.4662 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 13:15:05 UTC -12.6462 17.4662 850000
THIRD HARMONIC BIO INC THRD 2023-03-29 12:45:05 UTC -12.6462 17.4662 850000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments